Anti-NGF autoantibodies and NGF in sera of Alzheimer patients and in normal subjects in relation to age

Autoimmunity

Volumn 26, Issue 3, 1997, Pages 189-194

  Dicou, Eleni ^a,c   Vermersch, Patrick ^b   Penisson Besnier, Isabelle ^a   Dubas, Fréderic ^a   Nerrière, Véronique ^a  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Aging; Alzheimer's disease; Anti NGF; Autoantibodies; Inflammation; NGF; Serum

Indexed keywords

AUTOANTIBODY; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR ANTIBODY;

ADULT; AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MALE;

EID: 0031468331     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916939708994740     Document Type: Article

References (23)

1. Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A. W., Coyle, J. T. and De Long, M. R. (1982). Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science, 215, 1237-1239.
2. Thoenen, H. (1991). The changing scene of neurotrophic factors. Trends Neurosci., 14, 165-170.
3. McGeer, P. L., McGeer, E., Rogers, J. and Sibley, J. (1990). Anti-inflammatory drugs and Alzheimer disease. Lancet, 335, 1037.
4. Schnabel, J. (1993). New Alzheimer's therapy suggested. Science, 260, 1719-1720.
5. Dicou, E., Hurez, D. and Nerriere, V. (1993). Natural autoantibodies against the nerve growth factor in autoimmune diseases. J. Neuroimmunol., 477, 159-168.
6. Dicou, E., Perrot, S., Menkes, C. J., Massen, C. and Nerriere, V. (1996). Nerve growth factor (NGF) autoantibodies and NGF in the synovial fluid: implications in spondylarthropathies. Autoimmunity, 24, 1-9.
7. Aloe, L., Skaper, S. D., Leon, A. and Levi-Montalcini, R. (1994). Nerve growth factor and autoimmune diseases. Autoimmunity, 19, 141-158.
8. Dicou, E., Nerriere, V., Naud, M. C. and deKozak, Y. (1994). NGF involvement in ocular inflammation: secretion by rat resident cells. NeuroReport, 6, 26-28.
9. Dicou, E., Masson, C., Jabbour, W. and Nerriere, V. (1993). Increased frequency of NGF in sera of rheumatoid arthritis and systemic lupus erythematosus patients. NeuroReport, 5, 321-324.
10. McKahnn, G., Drachman, D., Folstein, M., Katzman, R., Price, D. and Stadlan, E. M. (1984). Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer Disease. Neurology, 34, 939-944.
11. Mobley, W. C., Schenker, A. and Shooter, E. M. (1976). Characterization and isolation of proteolytically modified nerve growth factor. Biochem., 15, 5543-5551.
12. Heinrich, G. and Meyer, T. E. (1988). Nerve growth factor (NGF) is present in human placenta and semen, but undetectable in normal and Paget's disease blood: measurements with an anti-mouse-NGF enzyme immunoassay using a recombinant human NGF reference. Biochem. Biophys. Res. Commun., 155, 482-486.
13. Murase, K., Nabeshima, T., Robitaille, Y., Quirion, R., Ogawa, M. and Hayashi, K. (1993). NGF level is not decreased in the serum, brain-spinal fluid, hippocampus, or parietal cortex of individuals with Alzheimer's disease. Biochem. Biophys. Res. Commun., 193, 198-203.
14. Massaro, A. R., Soranzo, C., Bigon, E., Battiston, S., Morandi, A., Carnevale, A. and Callegaro, L. (1994). Nerve growth factor (NGF) in cerebrospinal fluid (CSF) from patients with various neurological disorders. Ital. J. Neurol. Sci., 15, 105-108.
15. Goedert, M., Fine, A., Hunt, S. P. and Ullrich, A. (1986). Nerve growth factor mRNA in peripheral and central rat tissues and in the human brain: normal levels in basal forebrain in Alzheimer's disease. Mol. Brain Res., 1, 85-92.
16. Ernfors, P., Lindefors, N., Chan-Palay, V. and Persson, H. (1990). Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type. Dementia, 1, 138-145.
17. Goedert, M., Fine, A., Dawbarn, D., Wilcock, G. K. and Chao, M. V. (1989). Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. Mol. Brain Res., 5, 1-7.
18. Higgins, G. A. and Mufson, E. J. (1989). NGF receptor gene expression is decreased in the nucleus basalis in Alzheimer's disease. Exp. Neurol., 106, 222-236.
19. Allen, S. J., MacGowan, S. H., Treanor, J. J. S., Feeney, R., Wilcock, G. K. and Dawbarn, D., (1991). Normal β-NGF content in Alzheimer's disease cerebral cortex and hippocampus. Neurosci. Lett., 131, 135-139.
20. Scott, S. A., Mufson, E. J., Weingartner, J. A., Skau, K. A. and Crutcher, K. A. (1995). Nerve growth factor in Alzheimer's disease: Increased levels throughout the brain coupled with declines in nucleus basalis. J. Neurosci., 15, 6213-6221.
21. Olson, L. (1993). NGF and the treatment of Alzheimer's disease. Exper. Neurol., 124, 5-15.
22. Weksler, M. E. and Schwab, R. (1992). The immunogenetics of immune senescence. Exper. Clin. Immunogenetics, 9, 182-187.
23. Dicou, E. and Nerriere, V. (1997). Evidence that natural autoantibodies against the nerve growth factor (NGF) may be potential carriers of NGF. J. Neuroimmunol., 75, 200-203.